Elevated levels of S100B have been observed in neurodegenerative diseases and brain injuries, such as Alzheimer’s Disease, Parkinson’s Disease, Down syndrome, and stroke, where it may act as a damage-associated molecular pattern (DAMP) protein [26, 27]. The gene discussed is S100B; the disease is early-onset autosomal dominant Alzheimer disease.